Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.
about
Mouse models of dengue virus infection for vaccine testingGuiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccineThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseMouse models to study dengue virus immunology and pathogenesisMapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in MiceIdentification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cellsScreening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developersT-cell immunity to infection with dengue virus in humans.A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 MiceType I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccinesUtility, limitations, and future of non-human primates for dengue research and vaccine developmentCD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in miceMiR-278-3p regulates pyrethroid resistance in Culex pipiens pallensCD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in MiceThe successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection.Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccineProtective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection.Self-replicating alphavirus RNA vaccines.A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys.Vaccines licensed and in clinical trials for the prevention of dengue.Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response.Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.Live attenuated vaccine: the first clinically approved dengue vaccine?T Cell Immunity to Zika and Dengue Viral Infections.Immune Response to Dengue and Zika.Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.The immunology of Zika Virus.Dengue vaccine development: challenges and emerging opportunitiesCross-reactive Dengue virus-specific CD8 T cells protect against Zika virus during pregnancy
P2860
Q24276139-0CC8EAE9-8DAB-4E0C-B44E-E9F714388779Q26782367-37588773-6D35-4425-92A7-484E58DC3D89Q26995782-F3EC9EA6-6706-4A71-8B90-2B576F8252BEQ27010151-155AF9E8-D72A-41D3-AB08-0785145E162BQ28223043-3758E060-AE76-4530-97B0-BB5431F07507Q28950660-FD32EE2F-E687-48CD-95DA-D63D481B854FQ29365117-32756602-9BFB-4CB1-915F-2D80BEC5A21DQ33414009-A2CE3F36-D304-4A4E-92C0-7A5A258A3312Q33422520-0DD411F2-E1B7-4D04-984F-0200B7E68B51Q33744074-CC1F03CB-BC35-4641-B41C-0B233D8AA816Q34238916-19DAFB2B-0351-4ED3-B48E-39972393A3D5Q34289194-DDC9B811-08F9-4BEB-8ECF-FE11B2FCF0B9Q35007789-402DA075-775C-4AA1-AB74-E1019458E833Q35760439-C7AB8556-1757-4C2C-9870-DCEE4256E1E7Q35779556-5C941DDD-D2FF-444F-B341-7C4214B53D7AQ35880666-A95FFA90-161F-4262-B2CB-E72D8229D17BQ37135489-D3EB5D1E-B9C5-4D7B-B3E1-3147369846A1Q37500519-6B97BF99-9835-4A9A-B7B6-885850A3EA32Q37604714-EF4A1D16-50D1-414B-9010-22BE1EF0258EQ38255634-E68BCF2B-3C7A-4C4C-B726-A1C0E80E952AQ38840631-B73B6D26-475C-43EA-B3E7-447587AB8BB5Q39023333-E91C592D-32BC-4004-B289-02E4F966A1BCQ39172722-FAC16177-C8CC-4515-88C1-FB7583AB3E09Q40190331-82842A56-65A2-472A-A40C-50BDC3A4FB9DQ41929035-29E1DED5-71A1-4B93-887C-F93A4320CE74Q42985743-AA3EBEAB-798B-40E4-9F86-CAEA823F657CQ42998710-A55AB381-D6A3-47C3-ACCD-4122EE2D6214Q46518619-0ABD71A4-59CF-4E0F-97DC-D59FB8EF03B3Q47551925-4BC029EB-7693-4DFD-9E10-EC754375BC23Q47562022-DB19D08F-F3C5-4163-8D99-5F869A981E0BQ51336389-6BBD0503-F0A2-4836-9F9C-9D4D6C6DAEDDQ53158319-14FBF67C-C440-4A70-99A7-BD74DF97D3D9Q56341981-ED8C8EC2-91A5-47B9-AAE9-501EA7903148
P2860
Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Role of humoral versus cellula ...... tive dengue vaccine candidate.
@ast
Role of humoral versus cellula ...... tive dengue vaccine candidate.
@en
type
label
Role of humoral versus cellula ...... tive dengue vaccine candidate.
@ast
Role of humoral versus cellula ...... tive dengue vaccine candidate.
@en
prefLabel
Role of humoral versus cellula ...... tive dengue vaccine candidate.
@ast
Role of humoral versus cellula ...... tive dengue vaccine candidate.
@en
P2093
P2860
P1433
P1476
Role of humoral versus cellula ...... tive dengue vaccine candidate.
@en
P2093
Laura J White
Raphaël M Zellweger
Robert E Johnston
Robyn Miller
William E Eddy
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003723
P577
2013-10-31T00:00:00Z